This document provides a daily equity report from Epic Research India on August 17, 2018. It includes the closing levels of various Indian indices such as Nifty and Sensex. It also provides analysis on the performance of different industry sectors. The document further includes analysis and recommendations from Epic Research analysts on various stocks like DLF, Sun Pharma, and Bank Nifty. It ends with a disclaimer regarding the risks of investing in equity markets.

1. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
DAILY EQUITY REPORT
Our Presence
Epic Research India
411 Milinda Manor (Suites 409- 417)
2 RNT Marg. Opp Central Mall
Indore (M.P.)
Hotline: +91 731 664 2300
Or give us a missed call at
026 5309 0639
HNI & NRI Sales Contact Australia
Mintara Road, Tarneit, Victoria. Post Code 3029
Phone.: +61 422 063855
HNI & NRI Sales Contact USA
2117 Arbor Vista Dr. Charlotte (NC)
Cell: +1 704 249 2315
Toll Free Number
1-800-200-9454
All queries should be directed to
Info@epicresearch.co

2. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
DAILY MARKET WRAPUP
INDIAN INDICES
INDEX CMP Change % Chg
NIFTY 11385.00 -50.10 -0.44
SENSEX 37663.56 -188.44 -0.50
-0.16
Index Current % Change Open High Low Prev. Close
AUTO 10,830.95 0.26 10,767.50 10,891.40 10,744.65 10,803.15
FIN SERVICE 11,536.45 -1.14 11,606.70 11,644.60 11,522.00 11,669.85
FMCG 31,731.25 0.02 31,701.65 31,848.50 31,532.05 31,725.25
IT 15,044.35 0.23 15,021.95 15,122.65 15,017.25 15,009.25
MEDIA 2,817.25 -1.38 2,846.75 2,851.00 2,786.30 2,856.80
METAL 3,337.05 -2.27 3,356.15 3,370.50 3,329.65 3,414.60
PHARMA 9,595.35 1.2 9,519.50 9,613.00 9,474.70 9,481.15
PSU BANK 3,127.45 -0.77 3,134.70 3,192.10 3,104.65 3,151.85
REALTY 273.65 -0.51 272.45 275.4 270.4 275.05
ENERGY 15,238.60 -0.47 15,263.40 15,382.90 15,202.95 15,309.85
INFRA 3,076.65 -0.55 3,083.75 3,103.95 3,068.70 3,093.60
MNC 14,575.10 -0.22 14,547.55 14,637.20 14,509.80 14,607.80
PSE 3,616.55 -0.12 3,618.45 3,642.20 3,611.40 3,620.80
SERV SECTOR 15,389.75 -0.53 15,417.45 15,490.95 15,371.85 15,471.40
GROWSECT 15 7,122.80 0.23 7,095.65 7,146.60 7,077.20 7,106.45

3. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
The Nifty 50 rebounded from two-day losses Tuesday and extended the rally on August 14 despite volatility in the rupee, which breached the 70
to a US dollar-mark.The index closed decisively above the psychological 11,400 levels despite mixed global cues, forming bullish candle on the
daily candlestick charts, the traders can make a short position around its crucial resistance levels of 10440-20 for the targets of 11350-300 in
nifty future with stoploss above 11480.
NIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
11483.00 11434.00 11400.00 11351.00 11317.00

4. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
The Nifty Bank index closed at 27,826.6. The important Pivot level, which will act as crucial support for the index, is placed at 27,733.04,
followed by 27,639.47. On the upside, key resistance levels are placed at 27,966.64, followed by 28,106.67, as per our suggestion buy on
support would be good opportunity here so we advice to buy bank nifty future around 27950-980 for the targets of 28100-27200 with stoploss
above 27900.
BANKNIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
28106.00 27966.00 27872.00 27732.00 27638.00

5. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
The particular counter has breaked its downtrend by making a reverse head and shoulder pattern, in short its making a trend reversal chart pattern.
In the earleir trading session it breaked its crucial resistance levekl of 205.50 and clsoed above it, so we adive you to buy dlf future around the
levels of 206.90-208 for the targets of 212-216 with stoploss below 203.
DLF FUTURE
EPIC RESEARCH– ANALYST SPEAKS

6. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
EPIC RESEARCH– ANALYST SPEAKS
With the good fundamental this particular script has also plus point with respect to its technical , it is maintaining its uptrend and closedd above
its crucial resistance level of 610, also it is trading at 52 weeks high point so buy on strength would be good opportunity to go with it here we
advice you to buy sunpharma around the levels of 612-615 for the the targets of 625-635 with stoploss below 605.
SUNPHARMA FUTURE

7. YOUR MINTVISORY Call us at +91-731-6642300
17 AUG 2018
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up
on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility.
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of
the information is the acceptance of this disclaimer. All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer
to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then
Serious Legal Actions can be taken.
DISCLAIMER